10 20 30 40 50 60 70 80 1L3Q - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER STRUCTURAL PROTEIN 28-FEB-02 1L3Q
TITLE H. RUFESCENS ABALONE SHELL LUSTRIN A CONSENSUS REPEAT, TITLE 2 FPGKNVNCTSGE, PH 7.4, 1-H NMR STRUCTURE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: LUSTRIN A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LUSTRIN A CONSENSUS REPEAT, RESIDUES 142-153; COMPND 5 SYNONYM: ARAGONITE-ASSOCIATED PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: NACRE LAYER
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: SOLID PHASE PEPTIDE SYNTHESIS (FMOC). SOURCE 4 OCCURS NATURALLY IN HALIOTIS RUFESCENS, CALIFORNIA RED SOURCE 5 ABALONE
KEYWDS LOOP, STRUCTURAL PROTEIN
EXPDTA SOLUTION NMR
AUTHOR J.S.EVANS,B.A.WUSTMAN,B.ZHANG,D.E.MORSE
REVDAT 3 24-FEB-09 1L3Q 1 VERSN REVDAT 2 26-APR-05 1L3Q 1 JRNL REMARK REVDAT 1 15-MAR-02 1L3Q 0
JRNL AUTH B.ZHANG,B.A.WUSTMAN,D.E.MORSE,J.S.EVANS JRNL TITL MODEL PEPTIDE STUDIES OF SEQUENCE REGIONS IN THE JRNL TITL 2 ELASTOMERIC BIOMINERALIZATION PROTEIN, LUSTRIN A. JRNL TITL 3 I. THE C-DOMAIN CONSENSUS-PG-, -NVNCT-MOTIF JRNL REF BIOPOLYMERS V. 63 358 2002 JRNL REFN ISSN 0006-3525 JRNL PMID 11920437 JRNL DOI 10.1002/BIP.10069
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER 3.0 REMARK 3 AUTHORS : HAGLER, OSGUTHORPE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE BASED ON 42 RESTRAINTS, 33 REMARK 3 NOE DISTANCE CONSTRAINTS, 9 DIHEDRAL ANGLE RESTRAINTS. REMARK 3 SIMULATED ANNEALING/MINIMIZATION WITH IMPLICIT SOLVENT REMARK 3 ELECTROSTATICS
REMARK 4 REMARK 4 1L3Q COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAR-02. REMARK 100 THE RCSB ID CODE IS RCSB015616.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 1 MM SODIUM PHOSPHATE, PH 7.4 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : PFG ROESY, PE-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 7 -69.30 -137.02 REMARK 500 SER A 10 -60.44 -122.75 REMARK 500 REMARK 500 REMARK: NULL
DBREF 1L3Q A 1 12 PDB 1L3Q 1L3Q 1 12
SEQRES 1 A 12 PHE PRO GLY LYS ASN VAL ASN CYS THR SER GLY GLU
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000